Interventional Cardiology and Peripheral Vascular Devices Market Size to Hit USD 63.80 Billion by 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Interventional Cardiology and Peripheral Vascular Devices Market

5.1. COVID-19 Landscape: Interventional Cardiology and Peripheral Vascular Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Interventional Cardiology and Peripheral Vascular Devices Market, By Product Type

8.1. Interventional Cardiology and Peripheral Vascular Devices Market Revenue and Volume, by Product Type

8.1.1 Angioplasty Stents

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Angioplasty Balloons

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Catheters

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Plaque Modification Devices

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Hemodynamic Flow Alteration

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Structural Heart Devices

8.1.6.1. Market Revenue and Volume Forecast

8.1.7. Accessories

8.1.7.1. Market Revenue and Volume Forecast

Chapter 9. Global Interventional Cardiology and Peripheral Vascular Devices Market, By Application

9.1. Interventional Cardiology and Peripheral Vascular Devices Market Revenue and Volume, by Application

9.1.1. Coronary Artery Disease (CAD)

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Peripheral Arterial Disease (PAD)

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Aneurysms & Venous Diseases

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Interventional Cardiology and Peripheral Vascular Devices Market, By End User

10.1. Interventional Cardiology and Peripheral Vascular Devices Market Revenue and Volume, by End User

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Ambulatory Surgical Centres (ASCs)

10.1.2.1. Market Revenue and Volume Forecast

Chapter 11. Global Interventional Cardiology and Peripheral Vascular Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product Type

11.1.2. Market Revenue and Volume Forecast, by Application

11.1.3. Market Revenue and Volume Forecast, by End User

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product Type

11.1.4.2. Market Revenue and Volume Forecast, by Application

11.1.4.3. Market Revenue and Volume Forecast, by End User

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product Type

11.1.5.2. Market Revenue and Volume Forecast, by Application

11.1.5.3. Market Revenue and Volume Forecast, by End User

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product Type

11.2.2. Market Revenue and Volume Forecast, by Application

11.2.3. Market Revenue and Volume Forecast, by End User

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product Type

11.2.4.2. Market Revenue and Volume Forecast, by Application

11.2.4.3. Market Revenue and Volume Forecast, by End User

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product Type

11.2.5.2. Market Revenue and Volume Forecast, by Application

11.2.5.3. Market Revenue and Volume Forecast, by End User

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product Type

11.2.6.2. Market Revenue and Volume Forecast, by Application

11.2.6.3. Market Revenue and Volume Forecast, by End User

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product Type

11.2.7.2. Market Revenue and Volume Forecast, by Application

11.2.7.3. Market Revenue and Volume Forecast, by End User

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product Type

11.3.2. Market Revenue and Volume Forecast, by Application

11.3.3. Market Revenue and Volume Forecast, by End User

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product Type

11.3.4.2. Market Revenue and Volume Forecast, by Application

11.3.4.3. Market Revenue and Volume Forecast, by End User

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product Type

11.3.5.2. Market Revenue and Volume Forecast, by Application

11.3.5.3. Market Revenue and Volume Forecast, by End User

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product Type

11.3.6.2. Market Revenue and Volume Forecast, by Application

11.3.6.3. Market Revenue and Volume Forecast, by End User

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product Type

11.3.7.2. Market Revenue and Volume Forecast, by Application

11.3.7.3. Market Revenue and Volume Forecast, by End User

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product Type

11.4.2. Market Revenue and Volume Forecast, by Application

11.4.3. Market Revenue and Volume Forecast, by End User

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product Type

11.4.4.2. Market Revenue and Volume Forecast, by Application

11.4.4.3. Market Revenue and Volume Forecast, by End User

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product Type

11.4.5.2. Market Revenue and Volume Forecast, by Application

11.4.5.3. Market Revenue and Volume Forecast, by End User

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product Type

11.4.6.2. Market Revenue and Volume Forecast, by Application

11.4.6.3. Market Revenue and Volume Forecast, by End User

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product Type

11.4.7.2. Market Revenue and Volume Forecast, by Application

11.4.7.3. Market Revenue and Volume Forecast, by End User

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product Type

11.5.2. Market Revenue and Volume Forecast, by Application

11.5.3. Market Revenue and Volume Forecast, by End User

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product Type

11.5.4.2. Market Revenue and Volume Forecast, by Application

11.5.4.3. Market Revenue and Volume Forecast, by End User

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product Type

11.5.5.2. Market Revenue and Volume Forecast, by Application

11.5.5.3. Market Revenue and Volume Forecast, by End User

Chapter 12. Company Profiles

12.1. Medtronic (Ireland)

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Boston Scientific (U.S.)

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Abbott (U.S.)

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Johnson & Johnson (U.S.)

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Terumo Corporation (Japan)

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Cordis Corporation (U.S.)

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Siemens Healthineers (Germany)

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Koninklijke Philips N.V. (Netherlands)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. B. Braun Melsungen AG (Germany)

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Edwards Lifesciences (U.S.)

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The interventional cardiology and peripheral vascular device market size was evaluated at USD 27.96 billion in 2025 and is predicted to reach USD 63.80 billion by 2035.

Answer : The interventional cardiology and peripheral vascular device market is expected to grow at a compound annual growth rate (CAGR) of around 8.60% from 2026 to 2035.

Answer : The major players in the interventional cardiology and peripheral vascular device market include Medtronic (Ireland),Boston Scientific (U.S.),Abbott (U.S.),Johnson & Johnson (U.S.),Terumo Corporation (Japan),Cordis Corporation (U.S.),Siemens Healthineers (Germany),Koninklijke Philips N.V.(Netherlands),B.Braun Melsungen AG(Germany),Edwards Lifesciences(U.S.),Cook Medical (U.S.),LivaNova PLC (U.K.),LeMaitre Vascular(U.S.),MicroPort Scientific Corporation (China),OrbusNeich (Hong Kong),Biotronik (Germany),Abbott Vascular(U.S.),Terumo Interventional Systems (Japan),Avinger, Inc.(U.S.),Shockwave Medical (U.S.)

Answer : The driving factors of the interventional cardiology and peripheral vascular device market are the growing prevalence of cardiovascular disease and the increasing ageing population.

Answer : North America region will lead the global interventional cardiology and peripheral vascular device market during the forecast period 2026 to 2035.